HON vs SGMO · P/E 36, rev $9.72B vs rev $57.8M
Honeywell International Inc (HON) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the HON and SGMO stock pages for the full models.
Not investment advice.